Naloxone does not affect cigarette smoking
Tóm tắt
In order to provide information about the hypothesis that endogenous opioids mediate the reinforcing properties of cigarette smoking, the present study examined the effects of naloxone, an opioid antagonist, on cigarette smoking in seven normal volunteers. The study used experimental procedures that had previously been shown sensitive for detecting the effects of other drugs, (including a nicotine antagonist) on smoking. Isolated subjects smoked their regular brand of cigarettes freely in a naturalistic laboratory environment while watching television or reading. Sixty minutes before each 2 h smoking session subjects received an IM injection of naloxone HCl (0.0625, 0.25, 1.0, or 4.0 mg/kg) or placebo. Each subject received each treatment three times in a mixed order across days. Naloxone did not significantly affect any measure of cigarette smoking including number of cigarettes, number of puffs, or expired air carbon monoxide level. Naloxone did, however, produce significant dose-related increases in subject ratings of yawning, stretching, and relaxation. The results of the present study provide no support for the endogenous opioid theory of smoking reinforcement.
Tài liệu tham khảo
Berkowitz BA, Ngai SH, Hempstead J, Spector S (1975) Disposition of naloxone: Use of a new radioimmunoassay. J Pharmacol Exp Ther 195:499–504
Bigelow GE, Stitzer ML, Griffiths RR, Liebson IA (1981) Human methadone detoxification: Opioid self-administration behavior, cigarette smoking, and withdrawal signs and symptoms as a function of progressive dose reductions. Fed Proc 40:296
Chait LD, Griffiths RR (1982) Differential control of puff duration and interpuff interval in cigarette smokers. Pharmacol Biochem Behav 17:155–158
Chait LD, Griffiths RR (1983) Effects of caffeine on cigarette smoking and subjective response. Clin Pharm Ther 34:612–622
Chait LD, Griffiths RR (1984) Effects of methadone on human cigarette smoking and subjective Ratings. J Pharmacol Exp Ther 229:636–640
Chernick V (1983) The brain's own morphine and cigarette smoking: The junkie in disguise? Chest 83:2–4
Cohen MR, Cohen RM, Pickar D, Weingartner H, Murphy DL (1983) High dose naloxone infusions in normals: Dose-dependent behavioral, hormonal, and physiological responses. Arch Gen Psychiatry 40:613–619
Du Pont Pharmaceuticals Product Information for Narcan® (1985) In: Huff BB (ed) Physicians' Desk Reference, 39th Edition. Medical Economics Company Inc., Oradell, New Jersey, pp 922–923
Fishman J, Roffwang H, Hellman L (1973) Disposition of naloxone-7,8-3H in normal and narcotic dependent men. J Pharmacol Exp Ther 187:575–580
Haertzen CA, Hickey JE (1986) Measurement of euphoria and other drug effects. In: Bozarth M.A. (ed) Methods of assessing the reinforcing properties of abused drugs. Brunswick, Maine: Haer Institute (in press)
Henningfield JE, Chait LD, Griffiths RR (1983) Cigarette smoking and subjective response in alcoholics: Effects of pentobarbital. Clin Pharmacol Ther 33:806–812
Henningfield JE, Chait LD, Griffiths RR (1984) Effects of ethanol on cigarette smoking by volunteers without histories of alcoholism. Psychopharmacology 82:1–5
Henningfield JE, Griffiths RR (1979) A preparation for the experimental analysis of human cigarette smoking behavior. Behav Res Methods Instrum 11:538–544
Jarvis MJ, Russell MAH, Saloojee Y (1980) Expired air carbon monoxide: A simple breath test of tobacco smoke intake. Br Med J 281:484–485
Jasinski DR, Martin WR, Haertzen CA (1967) The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). J Pharmacol Exp Ther 157:420–426
Karras A, Kane JM (1980) Naloxone reduces cigarette smoking. Life Sci 27:1541–1545
Keppel G (1973) Design and analysis: A research handbook. Englewood Cliffs, New Jersey: Prentice Hall
McNair DM, Lorr M, Droppleman LF (1971) Profile of Mood States (Manual) San Diego, California: Educational and Industrial Testing Service
Mello NK, Lukas SE, Mendelson JH (1985) Buprenorphine effects on cigarette smoking. Psychopharmacology 86:417–425
Mello NK, Mendelson JH, Sellers ML, Kuehnle JC (1980) Effects of heroin self-administration on cigarette smoking. Psychopharmacology 67:45–52
Nemeth-Coslett R, Henningfield JE, O'Keeffe MK, Griffiths RR (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology (in press)
Pomerleau OF, Fertig JB, Seyler LE, Jaffe J (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81:61–67
Preston KL, Griffiths RR, Stitzer ML, Bigelow GE, Liebson IA (1984) Diazepam and methadone interactions in methadone maintenance. Clin Pharmacol Ther 36:534–541
Tobin MJ, Jenouri G, Sachner MA (1982) Effect of naloxone on change in breathing pattern with smoking: A hypothesis on the addictive nature of cigarette smoking. Chest 82:530–537